A Centers for Disease Control and Prevention panel will meet Wednesday to consider possible changes to COVID-19 vaccinations for young adults after reports of heart inflammation among a small number of teenage vaccine recipients.
There have been several hundred cases of this inflammation, also known as myocarditis, after the Food and Drug Administration authorized Pfizer’s COVID-19 vaccine for minors 12 and older.
The vaccine safety group said in May the “relatively few” reports of myocarditis “appear to be mild” and are below the expected baseline rates. Read more here.
Meanwhile, the delta variant now represents more than 20% of coronavirus infections in the U.S. in the last two weeks, or double what it was when the